

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | opsonization (GO:0008228) | 9.51317934 |
| 2 | complement activation, alternative pathway (GO:0006957) | 8.46941102 |
| 3 | regulation of integrin activation (GO:0033623) | 8.01931189 |
| 4 | drug catabolic process (GO:0042737) | 7.86245486 |
| 5 | exogenous drug catabolic process (GO:0042738) | 7.80209454 |
| 6 | apoptotic cell clearance (GO:0043277) | 7.43430756 |
| 7 | glyoxylate metabolic process (GO:0046487) | 7.29887341 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 7.21183353 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.21183353 |
| 10 | mannose metabolic process (GO:0006013) | 7.17326166 |
| 11 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 6.62494358 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 6.51840048 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.51840048 |
| 14 | regulation of complement activation (GO:0030449) | 6.36266139 |
| 15 | blood coagulation, intrinsic pathway (GO:0007597) | 6.16674278 |
| 16 | regulation of protein activation cascade (GO:2000257) | 6.07518314 |
| 17 | lipoxygenase pathway (GO:0019372) | 6.05428304 |
| 18 | urea metabolic process (GO:0019627) | 5.98726703 |
| 19 | cellular glucuronidation (GO:0052695) | 5.96288514 |
| 20 | ethanol oxidation (GO:0006069) | 5.85596267 |
| 21 | uronic acid metabolic process (GO:0006063) | 5.81524337 |
| 22 | glucuronate metabolic process (GO:0019585) | 5.81524337 |
| 23 | drug metabolic process (GO:0017144) | 5.76344883 |
| 24 | bile acid biosynthetic process (GO:0006699) | 5.75122230 |
| 25 | complement activation (GO:0006956) | 5.60714293 |
| 26 | oxidative demethylation (GO:0070989) | 5.59336714 |
| 27 | phenylpropanoid metabolic process (GO:0009698) | 5.44520027 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 5.39928382 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.35541904 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 5.28356957 |
| 31 | aromatic amino acid family catabolic process (GO:0009074) | 5.27274175 |
| 32 | epoxygenase P450 pathway (GO:0019373) | 5.12079048 |
| 33 | urea cycle (GO:0000050) | 5.09334892 |
| 34 | bile acid metabolic process (GO:0008206) | 5.04614010 |
| 35 | regulation of plasminogen activation (GO:0010755) | 5.02900464 |
| 36 | endothelial cell chemotaxis (GO:0035767) | 5.02009275 |
| 37 | acylglycerol homeostasis (GO:0055090) | 5.01074353 |
| 38 | triglyceride homeostasis (GO:0070328) | 5.01074353 |
| 39 | citrulline biosynthetic process (GO:0019240) | 4.90745871 |
| 40 | regulation of humoral immune response (GO:0002920) | 4.89046464 |
| 41 | glycine metabolic process (GO:0006544) | 4.87236648 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.75155909 |
| 43 | protein carboxylation (GO:0018214) | 4.75155909 |
| 44 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.74970482 |
| 45 | detection of molecule of bacterial origin (GO:0032490) | 4.73036069 |
| 46 | ethanol metabolic process (GO:0006067) | 4.72931109 |
| 47 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.71574719 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.70606010 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.70606010 |
| 50 | germinal center formation (GO:0002467) | 4.70242838 |
| 51 | negative regulation of hemostasis (GO:1900047) | 4.68937093 |
| 52 | negative regulation of blood coagulation (GO:0030195) | 4.68937093 |
| 53 | bile acid and bile salt transport (GO:0015721) | 4.64054984 |
| 54 | complement activation, classical pathway (GO:0006958) | 4.61088793 |
| 55 | alkaloid metabolic process (GO:0009820) | 4.39074789 |
| 56 | regulation of endothelial cell chemotaxis (GO:2001026) | 4.38155632 |
| 57 | negative regulation of wound healing (GO:0061045) | 4.33630809 |
| 58 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.30869798 |
| 59 | negative regulation of coagulation (GO:0050819) | 4.30760682 |
| 60 | protein activation cascade (GO:0072376) | 4.29938918 |
| 61 | regulation of macrophage chemotaxis (GO:0010758) | 4.29040352 |
| 62 | positive regulation of hemostasis (GO:1900048) | 4.20127929 |
| 63 | positive regulation of blood coagulation (GO:0030194) | 4.20127929 |
| 64 | omega-hydroxylase P450 pathway (GO:0097267) | 4.13676625 |
| 65 | S-adenosylmethionine metabolic process (GO:0046500) | 4.11405508 |
| 66 | amino-acid betaine metabolic process (GO:0006577) | 4.10915019 |
| 67 | acute-phase response (GO:0006953) | 4.08859556 |
| 68 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 4.04908735 |
| 69 | positive regulation of coagulation (GO:0050820) | 3.99469726 |
| 70 | cytokine production involved in immune response (GO:0002367) | 3.99118227 |
| 71 | arginine metabolic process (GO:0006525) | 3.97894034 |
| 72 | lymph node development (GO:0048535) | 3.97719331 |
| 73 | protein-lipid complex remodeling (GO:0034368) | 3.92440589 |
| 74 | macromolecular complex remodeling (GO:0034367) | 3.92440589 |
| 75 | plasma lipoprotein particle remodeling (GO:0034369) | 3.92440589 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 3.91488889 |
| 77 | intestinal cholesterol absorption (GO:0030299) | 3.91007902 |
| 78 | imidazole-containing compound metabolic process (GO:0052803) | 3.87534424 |
| 79 | cellular extravasation (GO:0045123) | 3.86568270 |
| 80 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.79472352 |
| 81 | keratan sulfate catabolic process (GO:0042340) | 3.78624821 |
| 82 | tyrosine metabolic process (GO:0006570) | 3.77373490 |
| 83 | hormone catabolic process (GO:0042447) | 3.76731758 |
| 84 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.76366488 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.75248181 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.75248181 |
| 87 | negative regulation of lipase activity (GO:0060192) | 3.71567802 |
| 88 | regulation of phagocytosis (GO:0050764) | 3.68746772 |
| 89 | steroid catabolic process (GO:0006706) | 3.68134192 |
| 90 | flavonoid metabolic process (GO:0009812) | 3.66476080 |
| 91 | regulation of T cell migration (GO:2000404) | 3.66062358 |
| 92 | positive regulation of T cell chemotaxis (GO:0010820) | 3.63746985 |
| 93 | regulation of T cell chemotaxis (GO:0010819) | 3.63746985 |
| 94 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.62694245 |
| 95 | negative regulation of cell killing (GO:0031342) | 3.62694245 |
| 96 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.58890351 |
| 97 | indole-containing compound catabolic process (GO:0042436) | 3.54910462 |
| 98 | indolalkylamine catabolic process (GO:0046218) | 3.54910462 |
| 99 | tryptophan catabolic process (GO:0006569) | 3.54910462 |
| 100 | cholesterol efflux (GO:0033344) | 3.50793979 |
| 101 | alpha-amino acid catabolic process (GO:1901606) | 3.50557777 |
| 102 | regulation of cholesterol esterification (GO:0010872) | 3.49814887 |
| 103 | citrulline metabolic process (GO:0000052) | 3.48920341 |
| 104 | high-density lipoprotein particle remodeling (GO:0034375) | 3.45057752 |
| 105 | xenobiotic metabolic process (GO:0006805) | 3.44956385 |
| 106 | reverse cholesterol transport (GO:0043691) | 3.44793910 |
| 107 | heme transport (GO:0015886) | 3.43653864 |
| 108 | negative regulation of complement activation (GO:0045916) | 3.39808626 |
| 109 | aromatic amino acid family metabolic process (GO:0009072) | 3.38321373 |
| 110 | negative regulation of protein activation cascade (GO:2000258) | 3.37540454 |
| 111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.37117371 |
| 112 | positive regulation of phagocytosis (GO:0050766) | 3.33473912 |
| 113 | leukotriene metabolic process (GO:0006691) | 3.33073145 |
| 114 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.30548829 |
| 115 | chronic inflammatory response (GO:0002544) | 3.29635831 |
| 116 | cellular ketone body metabolic process (GO:0046950) | 3.28806513 |
| 117 | polyketide metabolic process (GO:0030638) | 3.27679689 |
| 118 | doxorubicin metabolic process (GO:0044598) | 3.27679689 |
| 119 | daunorubicin metabolic process (GO:0044597) | 3.27679689 |
| 120 | acute inflammatory response (GO:0002526) | 3.27337304 |
| 121 | primary alcohol metabolic process (GO:0034308) | 3.26415722 |
| 122 | serine family amino acid biosynthetic process (GO:0009070) | 3.25680137 |
| 123 | production of molecular mediator of immune response (GO:0002440) | 3.24010400 |
| 124 | positive regulation of Rap GTPase activity (GO:0032854) | 3.22435126 |
| 125 | regulation of phospholipase A2 activity (GO:0032429) | 3.22220086 |
| 126 | glutamate metabolic process (GO:0006536) | 3.21031496 |
| 127 | negative regulation of granulocyte differentiation (GO:0030853) | 3.20866694 |
| 128 | positive regulation of lipid catabolic process (GO:0050996) | 3.20534213 |
| 129 | respiratory burst (GO:0045730) | 3.17672522 |
| 130 | cysteine metabolic process (GO:0006534) | 3.17136456 |
| 131 | negative regulation of interleukin-12 production (GO:0032695) | 3.16811887 |
| 132 | xenobiotic catabolic process (GO:0042178) | 3.15598219 |
| 133 | platelet degranulation (GO:0002576) | 3.14071508 |
| 134 | regulation of acute inflammatory response (GO:0002673) | 3.14015749 |
| 135 | collagen fibril organization (GO:0030199) | 3.12498700 |
| 136 | arachidonic acid metabolic process (GO:0019369) | 3.07628769 |
| 137 | fatty acid derivative biosynthetic process (GO:1901570) | 3.06726117 |
| 138 | icosanoid biosynthetic process (GO:0046456) | 3.06726117 |
| 139 | negative regulation of fibrinolysis (GO:0051918) | 3.05597869 |
| 140 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.03404976 |
| 141 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.00509910 |
| 142 | activated T cell proliferation (GO:0050798) | 2.98926231 |
| 143 | plasma lipoprotein particle clearance (GO:0034381) | 2.98832168 |
| 144 | detection of external biotic stimulus (GO:0098581) | 2.97358712 |
| 145 | positive regulation of extracellular matrix organization (GO:1903055) | 2.93995549 |
| 146 | prostaglandin metabolic process (GO:0006693) | 2.90078048 |
| 147 | prostanoid metabolic process (GO:0006692) | 2.90078048 |
| 148 | regulation of lymphocyte migration (GO:2000401) | 2.89105511 |
| 149 | regulation of mononuclear cell migration (GO:0071675) | 2.88158371 |
| 150 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.85212400 |
| 151 | cyclooxygenase pathway (GO:0019371) | 2.82223234 |
| 152 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.81857374 |
| 153 | fibrinolysis (GO:0042730) | 2.78515725 |
| 154 | peptidyl-proline hydroxylation (GO:0019511) | 2.77869045 |
| 155 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.77534336 |
| 156 | phagocytosis (GO:0006909) | 2.77028300 |
| 157 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.76906940 |
| 158 | unsaturated fatty acid biosynthetic process (GO:0006636) | 2.74532232 |
| 159 | regulation of Rap GTPase activity (GO:0032317) | 2.68777991 |
| 160 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.66411334 |
| 161 | alpha-linolenic acid metabolic process (GO:0036109) | 2.63884828 |
| 162 | regulation of cholesterol storage (GO:0010885) | 2.63878190 |
| 163 | fibril organization (GO:0097435) | 2.62699440 |
| 164 | endothelial cell morphogenesis (GO:0001886) | 2.61884879 |
| 165 | regulation of cell adhesion mediated by integrin (GO:0033628) | 2.61867628 |
| 166 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.60978112 |
| 167 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.60186361 |
| 168 | positive regulation of osteoblast proliferation (GO:0033690) | 2.59352787 |
| 169 | hyaluronan catabolic process (GO:0030214) | 2.59001781 |
| 170 | basement membrane organization (GO:0071711) | 2.58964093 |
| 171 | negative regulation of humoral immune response (GO:0002921) | 2.56110861 |
| 172 | nitric oxide biosynthetic process (GO:0006809) | 2.55252194 |
| 173 | cell adhesion mediated by integrin (GO:0033627) | 2.53845568 |
| 174 | regulation of fibrinolysis (GO:0051917) | 2.53450413 |
| 175 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.53032680 |
| 176 | phospholipid efflux (GO:0033700) | 2.52115711 |
| 177 | regulation of apoptotic cell clearance (GO:2000425) | 10.0577643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 4.81890959 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.50044255 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.16660491 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.91358370 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.53193856 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.51824334 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.02915378 |
| 8 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.98796433 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.82426474 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.80257553 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.63888527 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.55117774 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.53819877 |
| 14 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.22921215 |
| 15 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.18690352 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.18038735 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.16121615 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.07233874 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98430616 |
| 20 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95783618 |
| 21 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.94905619 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.93896859 |
| 23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.84184586 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.83256472 |
| 25 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.82877661 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76428616 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.74973354 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72883657 |
| 29 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.70895793 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70830719 |
| 31 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.69298196 |
| 32 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.67795859 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.64913590 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63720828 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.63720218 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62073695 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.60572702 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.59301607 |
| 39 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.54922955 |
| 40 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.54922955 |
| 41 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.52273709 |
| 42 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52132128 |
| 43 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.50599656 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49987718 |
| 45 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.49468764 |
| 46 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.45592835 |
| 47 | TP53_16413492_ChIP-PET_HCT116_Human | 1.44174016 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42437749 |
| 49 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.41569947 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39608144 |
| 51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.39392499 |
| 52 | CJUN_26792858_Chip-Seq_BT549_Human | 1.39381923 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37850877 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36968024 |
| 55 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33133292 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.31094235 |
| 57 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.30960809 |
| 58 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30679306 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28508874 |
| 60 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.27899884 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27531073 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26216271 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25688022 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.24412292 |
| 65 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.23837772 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20401180 |
| 67 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20015542 |
| 68 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18286825 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18216435 |
| 70 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14266092 |
| 71 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13335171 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13044074 |
| 73 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12574352 |
| 74 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.11777733 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11538510 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11279457 |
| 77 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10028866 |
| 78 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09557586 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09298880 |
| 80 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08330912 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08177170 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07124655 |
| 83 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.06783078 |
| 84 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.06150841 |
| 85 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.05877419 |
| 86 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05208797 |
| 87 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03890198 |
| 88 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03480224 |
| 89 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01933037 |
| 90 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01463482 |
| 91 | * NFYA_21822215_ChIP-Seq_K562_Human | 1.00277468 |
| 92 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99771768 |
| 93 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.99054613 |
| 94 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98875571 |
| 95 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.98356486 |
| 96 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98095928 |
| 97 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.96641299 |
| 98 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96494947 |
| 99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96337140 |
| 100 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.95590355 |
| 101 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95286023 |
| 102 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95154574 |
| 103 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94399991 |
| 104 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93779901 |
| 105 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93229518 |
| 106 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.92921106 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92604505 |
| 108 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92569420 |
| 109 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92239562 |
| 110 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91657581 |
| 111 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91324874 |
| 112 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.91145742 |
| 113 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90791343 |
| 114 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90653343 |
| 115 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.90409743 |
| 116 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.90310580 |
| 117 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90200378 |
| 118 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90137530 |
| 119 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90098976 |
| 120 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.90032319 |
| 121 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.89433070 |
| 122 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89051647 |
| 123 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.88973910 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88288048 |
| 125 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87563190 |
| 126 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.87553961 |
| 127 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87289760 |
| 128 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.87099373 |
| 129 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87069540 |
| 130 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.86538022 |
| 131 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86460444 |
| 132 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85595592 |
| 133 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85322878 |
| 134 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.84807422 |
| 135 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84797266 |
| 136 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84674498 |
| 137 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84613987 |
| 138 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84264812 |
| 139 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.84013336 |
| 140 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.83624596 |
| 141 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.83271526 |
| 142 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.83061065 |
| 143 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82934371 |
| 144 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.82836684 |
| 145 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.82803893 |
| 146 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.82731388 |
| 147 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81974718 |
| 148 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81138218 |
| 149 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.80942735 |
| 150 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.80384094 |
| 151 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.80081156 |
| 152 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80062579 |
| 153 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.79987227 |
| 154 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.79837190 |
| 155 | * TBL1_22424771_ChIP-Seq_293T_Human | 0.78587567 |
| 156 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78341709 |
| 157 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.78201141 |
| 158 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.78166076 |
| 159 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.78141432 |
| 160 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78013577 |
| 161 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.77825203 |
| 162 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.77533830 |
| 163 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77501158 |
| 164 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77181907 |
| 165 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.76929104 |
| 166 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.76731396 |
| 167 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75450681 |
| 168 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.74952803 |
| 169 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.74638438 |
| 170 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.74528389 |
| 171 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.73951566 |
| 172 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.73752631 |
| 173 | CBP_21632823_ChIP-Seq_H3396_Human | 0.73686909 |
| 174 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.73361184 |
| 175 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.73138116 |
| 176 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.72983698 |
| 177 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.70528944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 7.27438030 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 7.23698611 |
| 3 | MP0003195_calcinosis | 5.19660889 |
| 4 | MP0009384_cardiac_valve_regurgitation | 4.88337275 |
| 5 | MP0003279_aneurysm | 4.39263284 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 4.33216974 |
| 7 | MP0001958_emphysema | 4.20598389 |
| 8 | MP0003724_increased_susceptibility_to | 4.12705122 |
| 9 | MP0005275_abnormal_skin_tensile | 4.03700059 |
| 10 | MP0003868_abnormal_feces_composition | 3.64719314 |
| 11 | MP0001666_abnormal_nutrient_absorption | 3.08659545 |
| 12 | MP0003436_decreased_susceptibility_to | 2.74815760 |
| 13 | MP0009840_abnormal_foam_cell | 2.73502606 |
| 14 | MP0009697_abnormal_copulation | 2.68870735 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.66182219 |
| 16 | MP0002876_abnormal_thyroid_physiology | 2.46160726 |
| 17 | MP0005503_abnormal_tendon_morphology | 2.33158343 |
| 18 | MP0002933_joint_inflammation | 2.24550528 |
| 19 | MP0010368_abnormal_lymphatic_system | 2.23540199 |
| 20 | * MP0001533_abnormal_skeleton_physiology | 2.05541299 |
| 21 | MP0005360_urolithiasis | 1.85237236 |
| 22 | MP0003075_altered_response_to | 1.79036874 |
| 23 | MP0000767_abnormal_smooth_muscle | 1.72732331 |
| 24 | MP0001790_abnormal_immune_system | 1.70026498 |
| 25 | MP0005387_immune_system_phenotype | 1.70026498 |
| 26 | MP0005023_abnormal_wound_healing | 1.68984414 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.67375000 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.56370938 |
| 29 | MP0002419_abnormal_innate_immunity | 1.50392723 |
| 30 | MP0000604_amyloidosis | 1.48170912 |
| 31 | MP0002295_abnormal_pulmonary_circulatio | 1.47110746 |
| 32 | MP0000685_abnormal_immune_system | 1.45848196 |
| 33 | MP0001851_eye_inflammation | 1.45196327 |
| 34 | MP0002108_abnormal_muscle_morphology | 1.38317215 |
| 35 | MP0002168_other_aberrant_phenotype | 1.37781293 |
| 36 | * MP0005390_skeleton_phenotype | 1.34555439 |
| 37 | MP0001764_abnormal_homeostasis | 1.29286403 |
| 38 | MP0003303_peritoneal_inflammation | 1.28423449 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.27839643 |
| 40 | MP0002139_abnormal_hepatobiliary_system | 1.27541241 |
| 41 | MP0002060_abnormal_skin_morphology | 1.25093106 |
| 42 | MP0004272_abnormal_basement_membrane | 1.25007029 |
| 43 | MP0001879_abnormal_lymphatic_vessel | 1.24925545 |
| 44 | MP0005025_abnormal_response_to | 1.24473705 |
| 45 | MP0005670_abnormal_white_adipose | 1.21693262 |
| 46 | MP0004947_skin_inflammation | 1.18983605 |
| 47 | MP0003566_abnormal_cell_adhesion | 1.17743218 |
| 48 | MP0010386_abnormal_urinary_bladder | 1.17686086 |
| 49 | MP0001661_extended_life_span | 1.17021749 |
| 50 | MP0005408_hypopigmentation | 1.15739768 |
| 51 | MP0000249_abnormal_blood_vessel | 1.14711104 |
| 52 | MP0003186_abnormal_redox_activity | 1.11969718 |
| 53 | MP0004233_abnormal_muscle_weight | 1.11320052 |
| 54 | MP0003329_amyloid_beta_deposits | 1.09614739 |
| 55 | MP0009053_abnormal_anal_canal | 1.08994080 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.08478673 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.06965517 |
| 58 | MP0005187_abnormal_penis_morphology | 1.06935096 |
| 59 | MP0003091_abnormal_cell_migration | 1.05100857 |
| 60 | MP0005365_abnormal_bile_salt | 1.04889259 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.03722567 |
| 62 | MP0001915_intracranial_hemorrhage | 1.01750949 |
| 63 | MP0006054_spinal_hemorrhage | 0.99129335 |
| 64 | MP0003011_delayed_dark_adaptation | 0.97694575 |
| 65 | MP0002971_abnormal_brown_adipose | 0.96801369 |
| 66 | MP0008004_abnormal_stomach_pH | 0.96235095 |
| 67 | MP0005464_abnormal_platelet_physiology | 0.95253488 |
| 68 | MP0010329_abnormal_lipoprotein_level | 0.94432516 |
| 69 | MP0000343_altered_response_to | 0.93405254 |
| 70 | MP0002166_altered_tumor_susceptibility | 0.92672405 |
| 71 | MP0009643_abnormal_urine_homeostasis | 0.90109111 |
| 72 | MP0003252_abnormal_bile_duct | 0.89327741 |
| 73 | MP0003646_muscle_fatigue | 0.88897353 |
| 74 | MP0009763_increased_sensitivity_to | 0.87728435 |
| 75 | MP0002405_respiratory_system_inflammati | 0.87591261 |
| 76 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86766255 |
| 77 | MP0005388_respiratory_system_phenotype | 0.86746380 |
| 78 | MP0002133_abnormal_respiratory_system | 0.86746380 |
| 79 | MP0005085_abnormal_gallbladder_physiolo | 0.85796362 |
| 80 | MP0001800_abnormal_humoral_immune | 0.85690142 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.85284205 |
| 82 | MP0002998_abnormal_bone_remodeling | 0.83058911 |
| 83 | MP0005165_increased_susceptibility_to | 0.82624417 |
| 84 | MP0001849_ear_inflammation | 0.82552676 |
| 85 | MP0002452_abnormal_antigen_presenting | 0.80432616 |
| 86 | MP0001542_abnormal_bone_strength | 0.79823778 |
| 87 | MP0000566_synostosis | 0.79789684 |
| 88 | MP0002128_abnormal_blood_circulation | 0.79226585 |
| 89 | MP0005508_abnormal_skeleton_morphology | 0.77827711 |
| 90 | MP0003300_gastrointestinal_ulcer | 0.77804341 |
| 91 | MP0005535_abnormal_body_temperature | 0.77767799 |
| 92 | MP0002282_abnormal_trachea_morphology | 0.76693451 |
| 93 | MP0003690_abnormal_glial_cell | 0.75513747 |
| 94 | MP0005166_decreased_susceptibility_to | 0.75042203 |
| 95 | MP0005197_abnormal_uvea_morphology | 0.74509675 |
| 96 | MP0002909_abnormal_adrenal_gland | 0.73986175 |
| 97 | MP0001845_abnormal_inflammatory_respons | 0.73883916 |
| 98 | MP0005332_abnormal_amino_acid | 0.73608281 |
| 99 | MP0001614_abnormal_blood_vessel | 0.72915334 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 0.72327463 |
| 101 | MP0003172_abnormal_lysosome_physiology | 0.72283529 |
| 102 | MP0005595_abnormal_vascular_smooth | 0.70651556 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.70569270 |
| 104 | MP0000609_abnormal_liver_physiology | 0.69397692 |
| 105 | MP0001243_abnormal_dermal_layer | 0.69289436 |
| 106 | MP0003448_altered_tumor_morphology | 0.68141778 |
| 107 | MP0009642_abnormal_blood_homeostasis | 0.67963844 |
| 108 | MP0004510_myositis | 0.67512483 |
| 109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65424452 |
| 110 | MP0008469_abnormal_protein_level | 0.65411137 |
| 111 | MP0002132_abnormal_respiratory_system | 0.64089319 |
| 112 | MP0009931_abnormal_skin_appearance | 0.62802664 |
| 113 | MP0002078_abnormal_glucose_homeostasis | 0.62614726 |
| 114 | MP0005395_other_phenotype | 0.60677741 |
| 115 | MP0005083_abnormal_biliary_tract | 0.59196424 |
| 116 | MP0002118_abnormal_lipid_homeostasis | 0.57637197 |
| 117 | MP0002723_abnormal_immune_serum | 0.56864194 |
| 118 | MP0002090_abnormal_vision | 0.56562428 |
| 119 | MP0000598_abnormal_liver_morphology | 0.55602598 |
| 120 | MP0003879_abnormal_hair_cell | 0.55164423 |
| 121 | MP0002420_abnormal_adaptive_immunity | 0.55064427 |
| 122 | MP0001177_atelectasis | 0.54899973 |
| 123 | MP0004134_abnormal_chest_morphology | 0.54646188 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.54107153 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.53935820 |
| 126 | MP0000689_abnormal_spleen_morphology | 0.53693943 |
| 127 | MP0000751_myopathy | 0.53273520 |
| 128 | MP0002135_abnormal_kidney_morphology | 0.53094222 |
| 129 | MP0001819_abnormal_immune_cell | 0.53065509 |
| 130 | MP0003795_abnormal_bone_structure | 0.52905287 |
| 131 | MP0000858_altered_metastatic_potential | 0.52825715 |
| 132 | MP0005220_abnormal_exocrine_pancreas | 0.52005704 |
| 133 | MP0002928_abnormal_bile_duct | 0.51311371 |
| 134 | MP0005164_abnormal_response_to | 0.50644058 |
| 135 | MP0005266_abnormal_metabolism | 0.49733717 |
| 136 | MP0005636_abnormal_mineral_homeostasis | 0.49605097 |
| 137 | MP0002249_abnormal_larynx_morphology | 0.48655294 |
| 138 | MP0005448_abnormal_energy_balance | 0.47324918 |
| 139 | MP0009379_abnormal_foot_pigmentation | 0.45011596 |
| 140 | MP0001756_abnormal_urination | 0.44797451 |
| 141 | MP0005084_abnormal_gallbladder_morpholo | 0.44688238 |
| 142 | MP0005334_abnormal_fat_pad | 0.44374820 |
| 143 | MP0009764_decreased_sensitivity_to | 0.42632877 |
| 144 | MP0001944_abnormal_pancreas_morphology | 0.39584914 |
| 145 | MP0005257_abnormal_intraocular_pressure | 0.39110235 |
| 146 | MP0004130_abnormal_muscle_cell | 0.36857884 |
| 147 | MP0008775_abnormal_heart_ventricle | 0.36504698 |
| 148 | MP0008872_abnormal_physiological_respon | 0.34855234 |
| 149 | MP0004883_abnormal_blood_vessel | 0.34797474 |
| 150 | MP0004142_abnormal_muscle_tone | 0.34400453 |
| 151 | MP0002837_dystrophic_cardiac_calcinosis | 0.33831651 |
| 152 | MP0009115_abnormal_fat_cell | 0.33620637 |
| 153 | MP0003953_abnormal_hormone_level | 0.33229244 |
| 154 | MP0003959_abnormal_lean_body | 0.33139223 |
| 155 | MP0003941_abnormal_skin_development | 0.33004069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 9.03872002 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.61536979 |
| 3 | Arterial tortuosity (HP:0005116) | 6.90284938 |
| 4 | Vascular tortuosity (HP:0004948) | 6.62504172 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.53289271 |
| 6 | Glomerulonephritis (HP:0000099) | 5.91661642 |
| 7 | Complement deficiency (HP:0004431) | 5.69959274 |
| 8 | Abnormality of complement system (HP:0005339) | 5.64272759 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.46047799 |
| 10 | Aortic aneurysm (HP:0004942) | 5.45983972 |
| 11 | Shallow orbits (HP:0000586) | 5.32485901 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 5.26053009 |
| 13 | Peritonitis (HP:0002586) | 5.15236935 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 4.79080152 |
| 15 | Dysostosis multiplex (HP:0000943) | 4.73594639 |
| 16 | Deep venous thrombosis (HP:0002625) | 4.53528710 |
| 17 | Spondylolisthesis (HP:0003302) | 4.49280486 |
| 18 | Protrusio acetabuli (HP:0003179) | 4.35197557 |
| 19 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.15789295 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 4.12431787 |
| 21 | Overgrowth (HP:0001548) | 4.09462800 |
| 22 | Hypolipoproteinemia (HP:0010981) | 4.06719823 |
| 23 | Abnormality of the intrinsic pathway (HP:0010989) | 3.97390231 |
| 24 | Mucopolysacchariduria (HP:0008155) | 3.91198403 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.91198403 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.76122432 |
| 27 | Nephritis (HP:0000123) | 3.73967954 |
| 28 | Cervical subluxation (HP:0003308) | 3.63979048 |
| 29 | Soft skin (HP:0000977) | 3.55897829 |
| 30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.55789858 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.55789858 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.55789858 |
| 33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.52384270 |
| 34 | Spontaneous abortion (HP:0005268) | 3.51858333 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 3.48437340 |
| 36 | Broad metatarsal (HP:0001783) | 3.42526470 |
| 37 | Cerebral aneurysm (HP:0004944) | 3.40710089 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 3.39096875 |
| 39 | Prolonged partial thromboplastin time (HP:0003645) | 3.36130509 |
| 40 | Cardiovascular calcification (HP:0011915) | 3.35521609 |
| 41 | Bladder diverticulum (HP:0000015) | 3.29330845 |
| 42 | Premature rupture of membranes (HP:0001788) | 3.22821692 |
| 43 | Hypoalphalipoproteinemia (HP:0003233) | 3.22330054 |
| 44 | Vertebral compression fractures (HP:0002953) | 3.20706651 |
| 45 | Osteomalacia (HP:0002749) | 3.20345335 |
| 46 | Hyperglycinemia (HP:0002154) | 3.19082110 |
| 47 | J-shaped sella turcica (HP:0002680) | 3.18182184 |
| 48 | Hand muscle atrophy (HP:0009130) | 3.16618830 |
| 49 | Mitral stenosis (HP:0001718) | 3.11344392 |
| 50 | Wormian bones (HP:0002645) | 3.10269407 |
| 51 | Generalized aminoaciduria (HP:0002909) | 3.09298820 |
| 52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.07566919 |
| 53 | Loss of speech (HP:0002371) | 3.07388144 |
| 54 | Delayed CNS myelination (HP:0002188) | 3.03671162 |
| 55 | Vascular calcification (HP:0004934) | 3.02209602 |
| 56 | Fat malabsorption (HP:0002630) | 2.95209653 |
| 57 | Dilatation of the ascending aorta (HP:0005111) | 2.94515630 |
| 58 | Beaking of vertebral bodies (HP:0004568) | 2.92361401 |
| 59 | Pustule (HP:0200039) | 2.89087752 |
| 60 | Aneurysm (HP:0002617) | 2.84844035 |
| 61 | Reduced antithrombin III activity (HP:0001976) | 2.84124838 |
| 62 | Menorrhagia (HP:0000132) | 2.80903618 |
| 63 | Short nail (HP:0001799) | 2.76175395 |
| 64 | Distal upper limb amyotrophy (HP:0007149) | 2.67541244 |
| 65 | Upper limb amyotrophy (HP:0009129) | 2.67541244 |
| 66 | * Joint stiffness (HP:0001387) | 2.66669961 |
| 67 | Nasal polyposis (HP:0100582) | 2.66344225 |
| 68 | Hyperphosphaturia (HP:0003109) | 2.62956456 |
| 69 | Hyperammonemia (HP:0001987) | 2.62021838 |
| 70 | Abnormality of methionine metabolism (HP:0010901) | 2.61384779 |
| 71 | Abnormality of the lumbar spine (HP:0100712) | 2.59698285 |
| 72 | Abnormality of the nasal mucosa (HP:0000433) | 2.52619690 |
| 73 | Aortic dissection (HP:0002647) | 2.51307131 |
| 74 | Rickets (HP:0002748) | 2.49611164 |
| 75 | Epidermoid cyst (HP:0200040) | 2.49267278 |
| 76 | Bronchomalacia (HP:0002780) | 2.45837177 |
| 77 | Xanthomatosis (HP:0000991) | 2.45619925 |
| 78 | Steatorrhea (HP:0002570) | 2.44788307 |
| 79 | Ovoid vertebral bodies (HP:0003300) | 2.43843091 |
| 80 | Abnormality of serum amino acid levels (HP:0003112) | 2.42465734 |
| 81 | Abnormality of nucleobase metabolism (HP:0010932) | 2.40458830 |
| 82 | Bowel diverticulosis (HP:0005222) | 2.40415484 |
| 83 | Deformed sella turcica (HP:0002681) | 2.39648119 |
| 84 | Recurrent abscess formation (HP:0002722) | 2.36148223 |
| 85 | Glycosuria (HP:0003076) | 2.32704937 |
| 86 | Abnormality of urine glucose concentration (HP:0011016) | 2.32704937 |
| 87 | Abnormality of glycine metabolism (HP:0010895) | 2.30683139 |
| 88 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.30683139 |
| 89 | Eczematoid dermatitis (HP:0000976) | 2.30335603 |
| 90 | Fair hair (HP:0002286) | 2.24192855 |
| 91 | Joint hemorrhage (HP:0005261) | 2.20384094 |
| 92 | Polygenic inheritance (HP:0010982) | 2.19934127 |
| 93 | Coarse hair (HP:0002208) | 2.16633910 |
| 94 | Neurofibrillary tangles (HP:0002185) | 2.16379218 |
| 95 | Gastrointestinal infarctions (HP:0005244) | 2.14512462 |
| 96 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.11307125 |
| 97 | Thoracic kyphosis (HP:0002942) | 2.09544482 |
| 98 | Hypercholesterolemia (HP:0003124) | 2.07483347 |
| 99 | Abnormality of the peritoneum (HP:0002585) | 2.06845172 |
| 100 | Gingival bleeding (HP:0000225) | 2.05460950 |
| 101 | Hyperbilirubinemia (HP:0002904) | 2.05378096 |
| 102 | Decreased subcutaneous fat (HP:0001002) | 2.05112950 |
| 103 | Abnormal urine phosphate concentration (HP:0012599) | 2.04968699 |
| 104 | Emphysema (HP:0002097) | 2.02861939 |
| 105 | Abnormality of vitamin metabolism (HP:0100508) | 2.01377862 |
| 106 | Metabolic acidosis (HP:0001942) | 2.00691021 |
| 107 | Hepatocellular carcinoma (HP:0001402) | 2.00624880 |
| 108 | Fragile skin (HP:0001030) | 1.99437697 |
| 109 | Amyloidosis (HP:0011034) | 1.98651083 |
| 110 | Atrophic scars (HP:0001075) | 1.98265391 |
| 111 | Turricephaly (HP:0000262) | 1.98238296 |
| 112 | Opisthotonus (HP:0002179) | 1.94825967 |
| 113 | Neonatal hypoglycemia (HP:0001998) | 1.92179954 |
| 114 | Hypoplasia of the odontoid process (HP:0003311) | 1.91161439 |
| 115 | Abnormal biliary tract physiology (HP:0012439) | 1.90223824 |
| 116 | Bile duct proliferation (HP:0001408) | 1.90223824 |
| 117 | Biconcave vertebral bodies (HP:0004586) | 1.90029965 |
| 118 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.89287893 |
| 119 | Abnormality of skull ossification (HP:0002703) | 1.88719443 |
| 120 | Irritability (HP:0000737) | 1.87803312 |
| 121 | Hyperglycinuria (HP:0003108) | 1.87272640 |
| 122 | Broad face (HP:0000283) | 1.87229084 |
| 123 | Bradycardia (HP:0001662) | 1.87042167 |
| 124 | Flat acetabular roof (HP:0003180) | 1.84787107 |
| 125 | Striae distensae (HP:0001065) | 1.83301807 |
| 126 | Abnormality of the acetabulum (HP:0003170) | 1.82973163 |
| 127 | Toxemia of pregnancy (HP:0100603) | 1.82383715 |
| 128 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.81436913 |
| 129 | Blue sclerae (HP:0000592) | 1.81399644 |
| 130 | Cerebral inclusion bodies (HP:0100314) | 1.78585131 |
| 131 | Pulmonary embolism (HP:0002204) | 1.78074735 |
| 132 | Periodontitis (HP:0000704) | 1.76892733 |
| 133 | Atrioventricular block (HP:0001678) | 1.76704190 |
| 134 | Ketosis (HP:0001946) | 1.76384070 |
| 135 | Hypochromic microcytic anemia (HP:0004840) | 1.75082573 |
| 136 | Skin nodule (HP:0200036) | 1.74490239 |
| 137 | Abnormality of the Achilles tendon (HP:0005109) | 1.74327110 |
| 138 | Esophageal varix (HP:0002040) | 1.73790647 |
| 139 | Mitral valve prolapse (HP:0001634) | 1.73594054 |
| 140 | Enlarged penis (HP:0000040) | 1.72084209 |
| 141 | Atelectasis (HP:0100750) | 1.72014175 |
| 142 | Purpura (HP:0000979) | 1.71716538 |
| 143 | Multifactorial inheritance (HP:0001426) | 1.71412446 |
| 144 | Severe short stature (HP:0003510) | 1.71139740 |
| 145 | Abnormal delivery (HP:0001787) | 1.70515069 |
| 146 | Abnormality of the odontoid process (HP:0003310) | 1.69658317 |
| 147 | Gingivitis (HP:0000230) | 1.69547294 |
| 148 | Vertebral hypoplasia (HP:0008417) | 1.69052967 |
| 149 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.69052967 |
| 150 | Arachnodactyly (HP:0001166) | 1.68671184 |
| 151 | Recurrent bacterial skin infections (HP:0005406) | 1.68125198 |
| 152 | Cerebral edema (HP:0002181) | 1.67687820 |
| 153 | Retinal atrophy (HP:0001105) | 1.67112618 |
| 154 | Ectopia lentis (HP:0001083) | 1.66221302 |
| 155 | Prolonged bleeding time (HP:0003010) | 1.65981019 |
| 156 | Abnormal sex determination (HP:0012244) | 1.65311564 |
| 157 | Sex reversal (HP:0012245) | 1.65311564 |
| 158 | Hemorrhage of the eye (HP:0011885) | 1.64031651 |
| 159 | Facial shape deformation (HP:0011334) | 1.62396984 |
| 160 | Potter facies (HP:0002009) | 1.62396984 |
| 161 | Episodic fever (HP:0001954) | 1.62131489 |
| 162 | Inguinal hernia (HP:0000023) | 1.60873470 |
| 163 | Abnormality of purine metabolism (HP:0004352) | 1.60099034 |
| 164 | Thrombophlebitis (HP:0004418) | 1.59726471 |
| 165 | Pathologic fracture (HP:0002756) | 1.59009584 |
| 166 | Myocardial infarction (HP:0001658) | 1.58590259 |
| 167 | Generalized hypopigmentation of hair (HP:0011358) | 1.50450292 |
| 168 | Lethargy (HP:0001254) | 1.48450449 |
| 169 | * Arthropathy (HP:0003040) | 1.47686362 |
| 170 | Hypoglycemic coma (HP:0001325) | 1.47493027 |
| 171 | Hypophosphatemic rickets (HP:0004912) | 1.46384094 |
| 172 | Submucous cleft hard palate (HP:0000176) | 1.45008290 |
| 173 | Abnormal gallbladder morphology (HP:0012437) | 1.43156922 |
| 174 | Abnormality of iron homeostasis (HP:0011031) | 1.40943099 |
| 175 | Mesomelia (HP:0003027) | 1.40149877 |
| 176 | Increased serum ferritin (HP:0003281) | 1.39701967 |
| 177 | Elevated alkaline phosphatase (HP:0003155) | 1.38691116 |
| 178 | Torticollis (HP:0000473) | 1.38109746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 6.77574478 |
| 2 | ERN1 | 6.46918982 |
| 3 | MET | 3.09569966 |
| 4 | PNCK | 3.00175818 |
| 5 | NLK | 3.00045711 |
| 6 | CAMK1D | 2.81477318 |
| 7 | RIPK1 | 2.78239028 |
| 8 | BLK | 2.74355783 |
| 9 | TRIB3 | 2.70265652 |
| 10 | DAPK2 | 2.51434391 |
| 11 | STK16 | 2.38768186 |
| 12 | TAOK3 | 2.30881370 |
| 13 | EPHB1 | 2.27134737 |
| 14 | PKN2 | 2.23460771 |
| 15 | MYLK | 2.18343908 |
| 16 | CAMK1G | 2.18223890 |
| 17 | FRK | 2.09748243 |
| 18 | AKT3 | 1.99492053 |
| 19 | NTRK3 | 1.94583968 |
| 20 | BMX | 1.92729459 |
| 21 | TTN | 1.87888454 |
| 22 | MAPK15 | 1.84614193 |
| 23 | ABL2 | 1.82105141 |
| 24 | MUSK | 1.76457595 |
| 25 | MAP4K1 | 1.75505502 |
| 26 | TNIK | 1.75254363 |
| 27 | MAP3K3 | 1.73887375 |
| 28 | WNK3 | 1.71086322 |
| 29 | GRK1 | 1.68657009 |
| 30 | INSRR | 1.67462441 |
| 31 | TGFBR2 | 1.61579144 |
| 32 | PRKCG | 1.55732259 |
| 33 | DYRK2 | 1.54130445 |
| 34 | TAF1 | 1.52710468 |
| 35 | LATS1 | 1.49453237 |
| 36 | PIK3CA | 1.45287833 |
| 37 | TYK2 | 1.39628650 |
| 38 | MAP3K11 | 1.37658160 |
| 39 | TIE1 | 1.35956438 |
| 40 | PRKCE | 1.34889924 |
| 41 | MAP3K13 | 1.34435291 |
| 42 | CAMK1 | 1.33661502 |
| 43 | EPHB2 | 1.31038626 |
| 44 | IRAK1 | 1.27144068 |
| 45 | PINK1 | 1.26226250 |
| 46 | CAMKK2 | 1.26011549 |
| 47 | PTK6 | 1.25121339 |
| 48 | FES | 1.24225898 |
| 49 | CASK | 1.24095223 |
| 50 | SGK223 | 1.24057668 |
| 51 | SGK494 | 1.24057668 |
| 52 | PRKG1 | 1.22235905 |
| 53 | FGFR3 | 1.21055987 |
| 54 | NTRK1 | 1.20378766 |
| 55 | SGK2 | 1.19790125 |
| 56 | LATS2 | 1.19466812 |
| 57 | PRKAA2 | 1.18634885 |
| 58 | FGR | 1.16249125 |
| 59 | PRKCH | 1.14778432 |
| 60 | GRK6 | 1.13818981 |
| 61 | EPHA3 | 1.07946315 |
| 62 | CAMKK1 | 1.07457625 |
| 63 | WNK1 | 1.07008295 |
| 64 | MAP2K3 | 1.06591358 |
| 65 | TEC | 0.98879530 |
| 66 | DAPK1 | 0.98838748 |
| 67 | HCK | 0.97059682 |
| 68 | FGFR4 | 0.96705500 |
| 69 | CSK | 0.95554110 |
| 70 | ACVR1B | 0.94817262 |
| 71 | ADRBK2 | 0.93474801 |
| 72 | LRRK2 | 0.92862544 |
| 73 | ERBB4 | 0.92411252 |
| 74 | MAPKAPK3 | 0.91912086 |
| 75 | PDGFRA | 0.90740144 |
| 76 | STK10 | 0.89559556 |
| 77 | PTK2B | 0.87695494 |
| 78 | TBK1 | 0.86175623 |
| 79 | ZAP70 | 0.85536927 |
| 80 | FGFR1 | 0.85438419 |
| 81 | HIPK2 | 0.85095983 |
| 82 | PTK2 | 0.85095599 |
| 83 | OBSCN | 0.84341226 |
| 84 | PRKACA | 0.82137763 |
| 85 | MAPK12 | 0.79242315 |
| 86 | BCKDK | 0.78401530 |
| 87 | MAP3K7 | 0.78023871 |
| 88 | PDGFRB | 0.77573684 |
| 89 | RPS6KA4 | 0.76849270 |
| 90 | BMPR1B | 0.75685055 |
| 91 | KIT | 0.74946498 |
| 92 | UHMK1 | 0.71086057 |
| 93 | JAK3 | 0.68982322 |
| 94 | FLT3 | 0.68539993 |
| 95 | IGF1R | 0.67565480 |
| 96 | DAPK3 | 0.67275078 |
| 97 | TRPM7 | 0.66890513 |
| 98 | SIK2 | 0.66426186 |
| 99 | FER | 0.65564783 |
| 100 | SIK1 | 0.65005641 |
| 101 | JAK1 | 0.63841180 |
| 102 | EPHA4 | 0.63818215 |
| 103 | RIPK4 | 0.62872277 |
| 104 | STK3 | 0.61571301 |
| 105 | EPHA2 | 0.58946495 |
| 106 | MAP3K12 | 0.58017942 |
| 107 | PRKACB | 0.57968227 |
| 108 | DYRK3 | 0.57761654 |
| 109 | LCK | 0.56021874 |
| 110 | RPS6KA2 | 0.55177091 |
| 111 | ADRBK1 | 0.55060774 |
| 112 | SGK1 | 0.51423104 |
| 113 | FYN | 0.51058191 |
| 114 | MAP3K1 | 0.50372880 |
| 115 | GRK5 | 0.49622643 |
| 116 | MARK3 | 0.49365972 |
| 117 | EGFR | 0.49143235 |
| 118 | LIMK1 | 0.47766296 |
| 119 | MAP2K4 | 0.47666332 |
| 120 | CSNK1D | 0.47503443 |
| 121 | PRKCA | 0.47050569 |
| 122 | MAP3K6 | 0.47045462 |
| 123 | MAP2K1 | 0.46912939 |
| 124 | FGFR2 | 0.46558486 |
| 125 | PRKAA1 | 0.45813768 |
| 126 | BTK | 0.45723821 |
| 127 | DDR2 | 0.45385630 |
| 128 | MOS | 0.44690008 |
| 129 | CSF1R | 0.43369618 |
| 130 | MARK1 | 0.42480140 |
| 131 | STK38 | 0.42369289 |
| 132 | CAMK2D | 0.41708184 |
| 133 | STK38L | 0.41086092 |
| 134 | IRAK4 | 0.40530722 |
| 135 | PRKCZ | 0.39633709 |
| 136 | RPS6KA3 | 0.39383360 |
| 137 | RPS6KL1 | 0.38728766 |
| 138 | RPS6KC1 | 0.38728766 |
| 139 | JAK2 | 0.38726604 |
| 140 | RPS6KA6 | 0.38448812 |
| 141 | SGK3 | 0.37675577 |
| 142 | CSNK1E | 0.34720891 |
| 143 | RET | 0.34535181 |
| 144 | CDC42BPA | 0.34424491 |
| 145 | PDPK1 | 0.33938784 |
| 146 | DYRK1A | 0.32521551 |
| 147 | ERBB3 | 0.32475663 |
| 148 | TGFBR1 | 0.32446090 |
| 149 | ERBB2 | 0.31006203 |
| 150 | PAK3 | 0.30506579 |
| 151 | CAMK4 | 0.30241843 |
| 152 | MAPK4 | 0.30127457 |
| 153 | SYK | 0.29399262 |
| 154 | PIK3CG | 0.28984286 |
| 155 | GSK3A | 0.27802764 |
| 156 | MAPK7 | 0.27404630 |
| 157 | MAP3K9 | 0.26521632 |
| 158 | MAP3K10 | 0.26508750 |
| 159 | SRC | 0.26243794 |
| 160 | NEK9 | 0.25101861 |
| 161 | TAOK1 | 0.25003054 |
| 162 | PRKD1 | 0.24701037 |
| 163 | MATK | 0.24002192 |
| 164 | MAPKAPK2 | 0.22071371 |
| 165 | PRKACG | 0.22032348 |
| 166 | PIM2 | 0.21686503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 6.93498425 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.92540713 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 4.84630153 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.55550524 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.37232779 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.43859207 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.36053880 |
| 8 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.14984108 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.09213495 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.91433592 |
| 11 | Prion diseases_Homo sapiens_hsa05020 | 1.86989987 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.84820212 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.80524631 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.78836616 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.72994351 |
| 16 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.68653343 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.64552845 |
| 18 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.64417669 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.45259719 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35847179 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.27096799 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.23713968 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.16605395 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12901999 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12866809 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.12391336 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.12006361 |
| 28 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11254836 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.09970870 |
| 30 | Amoebiasis_Homo sapiens_hsa05146 | 1.07940754 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.05995687 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03831344 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.01908817 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98173482 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.97017527 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94721950 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88867612 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86100525 |
| 39 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.80998630 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80888743 |
| 41 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.80177980 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78127836 |
| 43 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74745495 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 0.74291921 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74288015 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73288551 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71917325 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 0.68218112 |
| 49 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66931736 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66557829 |
| 51 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66503606 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66332623 |
| 53 | Tuberculosis_Homo sapiens_hsa05152 | 0.66146223 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65097862 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.64997973 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.64787519 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.64682321 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.62545433 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62387100 |
| 60 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.62010441 |
| 61 | Peroxisome_Homo sapiens_hsa04146 | 0.60630495 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58883813 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58623613 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.58287113 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.57877293 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56239688 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55441100 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.55333055 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53815429 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53754939 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.52644743 |
| 72 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50527461 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49886611 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49656983 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47874659 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47839384 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46859085 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45243287 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.44638333 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43948286 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42506545 |
| 82 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42313119 |
| 83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42128291 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41613241 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41193340 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37808468 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37738736 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36589543 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.36268260 |
| 90 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35631697 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31981837 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31679361 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31666489 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.31252556 |
| 95 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30883609 |
| 96 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.30572885 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.28832375 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.26773395 |
| 99 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.26749378 |
| 100 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.26440369 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.24157074 |
| 102 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.23643897 |
| 103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.22875825 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.22847459 |
| 105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22466733 |
| 106 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21414116 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.20998075 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.20222143 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19912995 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19642955 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.18499451 |
| 112 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.18132078 |
| 113 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.17312828 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.16530396 |
| 115 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.16004052 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.15760558 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.14415002 |
| 118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.13626634 |
| 119 | Retinol metabolism_Homo sapiens_hsa00830 | 0.13595595 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.12985268 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12149209 |
| 122 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.11954926 |
| 123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.11721817 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09529724 |
| 125 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.06384616 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.04610076 |
| 127 | Circadian rhythm_Homo sapiens_hsa04710 | 0.02567497 |
| 128 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.00722892 |
| 129 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.1022379 |
| 130 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.1011103 |
| 131 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0977145 |
| 132 | Cocaine addiction_Homo sapiens_hsa05030 | -0.0670525 |
| 133 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0646224 |
| 134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0406899 |
| 135 | Protein export_Homo sapiens_hsa03060 | -0.0376510 |
| 136 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | -0.0190509 |
| 137 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0138759 |
| 138 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0118394 |
| 139 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0105379 |
| 140 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | -0.0018987 |

